Mixed urinary incontinence: a current view at the problem (review of clinical guidelines)
- Authors: Ermakova EI1
-
Affiliations:
- V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 4 (2018)
- Pages: 48-51
- Section: Articles
- URL: https://journals.rcsi.science/2079-5831/article/view/30107
- DOI: https://doi.org/10.26442/2079-5696_2018.4.48-51
- ID: 30107
Cite item
Full Text
Abstract
He purpose of the review - presentation of basic clinical scientific data based on current evidence on the management of patients with mixed urinary incontinence. Material and methods. A review of Russian and foreign sources on the prevalence, etiopathogenesis, diagnosis and treatment of mixed urinary incontinence in women. Results. The review presents terminology, data on etiopathogenesis, clinic, diagnosis, phasing and treatment methods of mixed urinary incontinence in women at different age periods.
Full Text
##article.viewOnOriginalSite##About the authors
E I Ermakova
V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
Email: ermakova.health@mail.ru
канд. мед. наук, ст. науч. сотр, секретарь Российской ассоциации по менопаузе 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4
References
- Hampel C, Weinhold D, Benken N et al. Prevalence and Natural History of Female Incontinence. Eur Urol 2007; 32 (Suppl. 2): 3-12.
- Abrams P, Cardozo L, Fall M et al. The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Cociety. Urology 2003; 61 (1): 37-49.
- Юренева С.В., Ермакова Е.И., Глазунова А.В. Диагностика и терапия генитоуринарного менопаузального синдрома у пациенток в пери- и постменопаузе (краткие клинические рекомендации). Акушерство и гинекология. 2016; 5.
- Monz D, Pons M, Hampel C et al. Patien - repoted impact of urinary incontinence. - Results from treatment seeking women in 14 European countries. Maturitas 2005; 52 (2): 25-8.
- Cameron A.P, Heidelbaugh J.J, Jimbo M. Diagnosis and office-based treatment of urinary incontinence in adults. Part one: diagnosis and testing. Ther Adv Urol 2013; 5 (4): 181-7
- Shah S.M, Gaunay G.S. Treatment options for intrinsic sphincter deficiency. Nat Rev Urol 2012; 9 (11): 638-51.
- Geoffrion R. No. 353-Treatments for Overactive Bladder: Focus on Pharmacotherapy - An Addendum. J Obstet Gynaecol Can 2017; 39 (12): 1221-9.
- Вишневский Е.Л., Пушкарь Д.Ю., Лоран О.Б. и др. Урофлоуметрия. М., 2004; с. 176-208, 263
- Baessler K, Christmann-Schmid C, Maher C et al. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst Rev 2018; 8.
- Petros P.E. Mixed urinary incontinence - time to uncouple urgency from stress. Int Urogynecol J 2011; 22 (8): 919-21.
- Lee J.K, Dwver P.L, Rosamila A et al. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis. BJOG 2011; 118 (7): 798-805.
- Stewart F, Berghmans B, Bø K, Glazener C.M. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev 2017; 12.
- Monteiro S, Riccetto C, Araújo A et al. Efficacy of pelvic floor muscle training in women with overactive bladder syndrome: a systematic review. Int Urogynecol J 2018.
- Kirchin V, Page T, Keegan P.E et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2017; 7.
- Khullar V, Amarenco G, Angulo J.C et al. Efficacy and tolerability of mirabegron, a b(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. Eur Urol 2013; 63 (2): 283-95.
- Chapple C, Kaplan S, Mitcheson H et al. Randomised, double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a b(3)adrenoceptor agonist, in overactive bladder (OAB). Eur Urol 2013; 62 (2): 296-305.
- The 2017 hormone therapy position statement of The North American Menopause Society NAMS. Menopause 2017; 24 (7).
Supplementary files

